Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mTOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01658176
What this trial is testing

Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer
Not applicableStudy completedNCT06976333
What this trial is testing

Tumor-Infiltrating Lymphocytes in Endometrial Cancer

Who this might be right for
Endometrium CancerTumor Infiltration
Jagiellonian University 52
Large-scale testing (Phase 3)Study completedNCT00789828
What this trial is testing

Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)

Who this might be right for
Tuberous SclerosisSubependymal Giant Cell Astrocytoma
Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)Study completedNCT01734512
What this trial is testing

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Who this might be right for
Pediatric Recurrent Progressive Low-grade GliomasPediatric Progressive Low-grade Gliomas
University of California, San Francisco 65
Testing effectiveness (Phase 2)Study completedNCT05663944
What this trial is testing

REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study

Who this might be right for
Advanced Chronic Liver Disease
Nottingham University Hospitals NHS Trust 41
Not applicableLooking for participantsNCT07646171
What this trial is testing

EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)

Who this might be right for
Hormone Receptor Positive Breast Cancer
Tel-Aviv Sourasky Medical Center 19
Testing effectiveness (Phase 2)Study completedNCT06132932
What this trial is testing

WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations

Who this might be right for
PIK3CA Mutation-Related Tumors
Shanghai Jiatan Pharmatech Co., Ltd 38
Post-approval studies (Phase 4)UnknownNCT01289301
What this trial is testing

Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant

Who this might be right for
Disorder Related to Renal TransplantationImmunosuppression Related Infectious DiseaseVirus Diseases
Hannover Medical School 124
Not applicableEnded earlyNCT03946774
What this trial is testing

Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling

Who this might be right for
Dietary Protein
Washington University School of Medicine 21
Testing effectiveness (Phase 2)UnknownNCT03664115
What this trial is testing

Itraconazole in Non Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Ain Shams University 60
Not applicableStudy completedNCT05563831
What this trial is testing

National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)

Who this might be right for
PIK3CA-related Overgrowth SpectrumCLOVES SyndromeKlippel Trenaunay Syndrome+6 more
Institut National de la Santé Et de la Recherche Médicale, France 28
Not applicableStudy completedNCT01358305
What this trial is testing

Protein Blends (Soy, Whey and Casein) for Muscle Synthesis

Who this might be right for
Muscle Synthesis
DuPont Nutrition and Health 19
Testing effectiveness (Phase 2)WithdrawnNCT01178151
What this trial is testing

Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome

Who this might be right for
Peutz-Jeghers SyndromeNeoplastic ProcessesNeoplasm Metastasis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Testing effectiveness (Phase 2)Study completedNCT01070316
What this trial is testing

Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)

Who this might be right for
EpilepsyTuberous Sclerosis Complex
Children's Hospital Medical Center, Cincinnati 20
Testing effectiveness (Phase 2)Study completedNCT00869999
What this trial is testing

Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Massachusetts General Hospital 26
Testing effectiveness (Phase 2)Study completedNCT05781698
What this trial is testing

Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis

Who this might be right for
Inflammatory Bowel Diseases
Tanta University 60
Large-scale testing (Phase 3)Study completedNCT00510068
What this trial is testing

Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Advanced Neuroendocrine Tumors of Pancreatic Origin
Novartis Pharmaceuticals 410
Large-scale testing (Phase 3)Study completedNCT01713946
What this trial is testing

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

Who this might be right for
Tuberous Sclerosis Complex-associated Refractory Seizures
Novartis Pharmaceuticals 366
Post-approval studies (Phase 4)Looking for participantsNCT06722586
What this trial is testing

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

Who this might be right for
Antiphospholipid (aPL)-PositiveThrombocytopaenia
Peking University First Hospital 84
Large-scale testing (Phase 3)Study completedNCT00876395
What this trial is testing

Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 719
Next Page